Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression

Vilazodone is a potent selective serotonin reuptake inhibitor and serotonin 1A receptor partial agonist approved for the treatment of major depressive disorder in adults. To assess the efficacy of vilazodone across a range of symptoms and severities of depression, data from two phase III, 8-week, ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Arif, Sambunaris, Angelo, Edwards, John, Ruth, Adam, Robinson, Donald S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901802/
https://www.ncbi.nlm.nih.gov/pubmed/24247740
http://dx.doi.org/10.1097/YIC.0000000000000016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901802/
https://www.ncbi.nlm.nih.gov/pubmed/24247740
http://dx.doi.org/10.1097/YIC.0000000000000016

Ejemplares similares